kegg

kegg is a manufacturer of a medical-grade fertility tracking device that monitors cervical mucus to help women identify their most fertile windows. The FDA-registered device uses advanced sensing technology to detect dynamic shifts in vaginal fluid, providing personalized fertility and cervical mucus scores through a companion mobile application in just one minute per day. Unlike traditional ovulation predictors, kegg tracks cervical mucus, the key fertility metric essential for sperm survival and successful fertilization. The device also includes guided kegel exercise routines for pelvic floor health optimization before labor and postpartum recovery. kegg serves women with PCOS, irregular cycles, and those conceiving after 40, with a pregnancy guarantee offering a full refund if conception does not occur. Trusted by over 100,000 couples, the device is constructed of medical-grade silicone with no monthly refill costs. Founded in 2017 and headquartered in San Francisco, United States, kegg has raised approximately .5 million in a Series A round backed by HAX, SOSV, Texas Halo Fund, Ad Astra Ventures, Crescent Ridge Partners, and Relentless Consumer Partners.